MNKD MannKind Corporation - Common Stock
NASDAQ · Biotechnology · SEC EDGAR पर देखें ↗ बंद अक्ट 2, 2026 10-K/10-Q अग 5, 2026
$3.80
· 52 सप्ताह की सीमा का %
· निम्न से ऊपर
· उच्च तक
$2.2352w निम्न
$6.5152w उच्च
मार्केट कैप (MRQ)
$1.18B
P/E (TTM)
-29.2
EPS (TTM)
$-0.13
राजस्व (TTM)
$394M
आपके बैज
52W रेंज
$2–$7
विश्लेषक रेटिंग
BUY
मूल्य लक्ष्य
$8
P/E
-29.2
ROE
71.4%
शुद्ध लाभ मार्जिन
-11.1%
आपकी बैज स्ट्रिप खाली है — इस पेज पर कहीं भी एक मीट्रिक पिन करें।
MNKD स्टॉक स्नैपशॉट मूल्य, बाजार पूंजीकरण, P/E, EPS, ROE, ऋण/इक्विटी, 52-सप्ताह की सीमा
मूल्य
$3.80
मार्केट कैप (MRQ)
$1.18B
P/E (TTM)
-29.2
EPS (TTM)
$-0.13
राजस्व (TTM)
$394M
ROE (TTM)
71.4%
52W रेंज
$2–$7
MNKD स्टॉक मूल्य चार्ट तकनीकी संकेतकों के साथ दैनिक OHLCV — पैन, ज़ूम और अपना दृश्य कस्टमाइज़ करें
सीमा
बार
बार ग्रैन्युलैरिटी चयनित अवधि के अनुसार अनुकूलित होती है — बार के लिए ओपन/हाई/लो/क्लोज देखने के लिए चार्ट पर होवर करें।
स्टॉक विभाजन
| एक्स-डेट | स्प्लिट | प्रकार |
|---|---|---|
| 3 मार्च 2017 | 1-for-5 | रिवर्स |
MannKind Corporation - Common Stock के बारे में विकिपीडिया से कंपनी का अवलोकन
MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991.
MannKind Corporation was named after its founder, Alfred E. Mann.
History
Founded in February 1991, the company's present form is a result of a 2003 merger of three companies owned by Alfred E. Mann: Pharmaceutical Discovery Corporation (PDC), the cancer vaccine developer CTL ImmunoTherapies, Inc., and its sister company Allecure Corp, which was developing an allergy vaccine technology. Pharmaceutical Discovery was purchased in 2001 from Solomon Steiner; with that purchase MannKind acquired the Technosphere molecule and Medtone inhaler, upon which was developed its lead product, Afrezza (inhalable insulin).
The FDA approved Afrezza on June 27, 2014.
On August 11, 2014 MannKind entered into an exclusive global licensing agreement with Sanofi for Afrezza sales. Under the agreement, MannKind received $150 million cash from Sanofi, in exchange for sharing profits and losses of sales of Afrezza, with 65% for Sanofi and 35% for MannKind. On January 5, 2016, MannKind Corporation announced the termination of the license and collaboration agreement with Sanofi. By December 2017, the company had lost 11% of its trading volume due to the poor sales.
In March 2020, the company announced it was working with fellow pharmaceutical company Immix Biopharma to try to develop an inhalable treatment for acute respiratory distress syndrome, a lung disease.
Products and product candidates
The firm has developed Afrezza a rapid-acting insulin peaking 12 to 15 minutes after inhalation and exiting the body within 2–3 hours. The inhalation technology uses a miniature, breath-powered inhaler in combination with single-use cartridges containing pre-metered doses. Initial pharmacokinetic studies were followed by studies of safety and efficiency involving Technosphere formulations of different therapeutic proteins.
Leadership
Mann was chief executive officer until January 12, 2015 when Hakan Edstrom became CEO and Mann transitioned to executive chairman.
In November 2015, Hakan Edstrom stepped down as CEO and president. Company founder Alfred Mann stepped in as interim CEO on November 19, 2015. In 2016, Matthew Pfeffer was appointed CEO of MannKind, and served as both CEO and CFO. In May 2017, Michael Castagna was named CEO of the company.
Facilities
MannKind has a large corporate office in Westlake Village, California. The Afrezza manufacturing facility is in Danbury, Connecticut. In 2022, the company moved its official headquarters to Danbury.
स्रोत: विकिपीडिया (अंग्रेज़ी), CC BY-SA 4.0 · विकिपीडिया पर देखें ↗
क्षेत्रHealthcare
उद्योगBiotechnology
कर्मचारी591
देशUS
10-वर्षीय प्रदर्शन राजस्व, शुद्ध आय, मार्जिन और ईपीएस रुझान
राजस्व$349M2016-12-31 → 2025-12-31
EPS$0.022016-12-31 → 2025-12-31
फ्री कैश फ्लो$14M2018-12-31 → 2025-12-31
शुद्ध मार्जिन-11.1%2017-12-31 → 2025-12-31
मूल्यांकन और अनुपात
मूल्यांकन P/E, P/S, P/B, EV/EBITDA अनुपात — क्या स्टॉक महंगा है या सस्ता?
| मेट्रिक | 5Y रुझान | MNKD | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| P/E (TTM) | -29.25Y औसत ≈45.5 | ≈45.5 | · | · | |
| P/S (TTM) | 3.05Y औसत ≈9.1 | ≈9.1 | 21.2 | अल्पमूल्यित | |
| P/B (MRQ) | -17.55Y औसत ≈-14.7 | ≈-14.7 | · | · | |
| मूल्य / FCF (TTM) | -64.95Y औसत ≈7.7 | ≈7.7 | · | · | |
| मूल्य / नकदी प्रवाह (TTM) | -146.25Y औसत ≈27.0 | ≈27.0 | · | · | |
| मूल्य / मूर्त पुस्तक (MRQ) | -16.3 | · | · | · |
सहकर्मी माध्यिका को प्रति मीट्रिक मानकीकृत आधार पर गणना की जाती है और यह हमेशा इस स्टॉक के लिए दिखाए गए TTM/MRQ आधार से मेल नहीं खा सकती है।
लाभप्रदता सकल, परिचालन और शुद्ध मार्जिन; ROE, ROA, ROIC
| मेट्रिक | 5Y रुझान | MNKD | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| परिचालन मार्जिन (TTM) | 2.3%5Y औसत ≈-17.1% | ≈-17.1% | -308.7% | शीर्ष स्तर | |
| EBITDA Margin (EBITDA मार्जिन) | 11.1%5Y औसत ≈-17.1% | ≈-17.1% | -308.7% | शीर्ष स्तर | |
| प्रीटैक्स मार्जिन (TTM) | -12.4%5Y औसत ≈-37.8% | ≈-37.8% | · | · | |
| शुद्ध लाभ मार्जिन (TTM) | -11.1%5Y औसत ≈-37.9% | ≈-37.9% | -214.0% | शीर्ष स्तर | |
| ROA (TTM) | -7.6%5Y औसत ≈-12.4% | ≈-12.4% | -44.4% | शीर्ष स्तर | |
| ROE (TTM) | 71.4%5Y औसत ≈10.3% | ≈10.3% | -11.7% | अनुरूप | |
| ROIC | -316.9%5Y औसत ≈-71.2% | ≈-71.2% | -128.0% | कमजोर |
वित्तीय स्वास्थ्य ऋण, तरलता, शोधन क्षमता — बैलेंस शीट की मजबूती
| मेट्रिक | 5Y रुझान | MNKD | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| वर्तमान अनुपात (MRQ) | 1.75Y औसत ≈3.3 | ≈3.3 | 10.6 | कम तरलता | |
| त्वरित अनुपात (MRQ) | 1.15Y औसत ≈2.8 | ≈2.8 | 5.1 | कम तरलता |
विकास राजस्व, EPS और शुद्ध आय वृद्धि: YoY, 3Y CAGR, 5Y CAGR
| मेट्रिक | 5Y रुझान | MNKD | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| Revenue YoY (राजस्व YoY) | 22.2%5Y औसत ≈42.6% | ≈42.6% | · | · | |
| Revenue CAGR 3Y (राजस्व CAGR 3Y) | 51.8%5Y औसत ≈50.9% | ≈50.9% | · | · | |
| Revenue CAGR 5Y (राजस्व CAGR 5Y) | 39.9% | · | · | · | |
| EPS YoY | -80.0% | · | · | · | |
| Net Income YoY (शुद्ध आय YoY) | -78.8% | · | · | · |
पूंजी दक्षता एसेट टर्नओवर, इन्वेंटरी टर्नओवर, प्राप्य टर्नओवर
| मेट्रिक | 5Y रुझान | MNKD | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| Asset Turnover (परिसंपत्ति टर्नओवर) | 0.65Y औसत ≈0.5 | ≈0.5 | 0.3 | शीर्ष स्तर | |
| Inventory Turnover (इन्वेंटरी टर्नओवर) | 0.85Y औसत ≈1.2 | ≈1.2 | · | · | |
| Receivables Turnover (प्राप्य टर्नओवर) | 13.95Y औसत ≈14.7 | ≈14.7 | · | · | |
| Revenue / Employee (राजस्व / कर्मचारी (रिपोर्ट की गई हेडकाउंट, यफाइनांस)। व्युत्पन्न — संग्रहीत SEC-XBRL अवधारणा नहीं है।) | ≈$590.5K | · | · | · |
मान · ≈ 5Y औसत · उद्योग माध्य · माध्य के सापेक्ष निर्णय
Earnings History EPS वास्तविक बनाम अनुमान, आश्चर्य %, बीट दर, अगली आय तिथि
औसत आश्चर्य
-86.3%
अगली रिपोर्ट
नव 03, 2026
| Period | रिपोर्ट | EPS Actual | EPS अनुमान | आश्चर्य |
|---|---|---|---|---|
| 30 जून 2026 | अग 12, 2026 | $-0.06 | $-0.00 | — |
| 31 मार्च 2026 | मई 13, 2026 | $-0.05 | $-0.00 | — |
| 31 दिसमबर 2025 | $-0.05 | $0.01 | -440.1% | |
| 30 सितमबर 2025 | $0.07 | $0.02 | 205.9% | |
| 30 जून 2025 | $0.00 | $0.05 | -100.0% | |
| 31 मार्च 2025 | $0.04 | $0.04 | -10.9% |
पूर्ण मौलिक सभी मेट्रिक्स प्रति वर्ष — आय विवरण, बैलेंस शीट, नकदी प्रवाह
आय विवरण
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $349M | $286M | $199M | $100M | $75M | $65M | $63M | $28M | $12M | $175M | $0 | $0 | |
| Cost of Revenue | $27M | $17M | $21M | $16M | $17M | $15M | $20M | $19M | $17M | $17M | $65M | · | |
| SG&A Expense | $144M | $94M | $94M | $91M | $32M | $25M | $75M | $80M | $75M | $47M | $41M | $79M | |
| Operating Expenses | $88M | $77M | $63M | $57M | $39M | $25M | $108M | $104M | $120M | $107M | $345M | $180M | |
| Operating Income | $39M | $73M | $9M | $-64M | $-47M | $-48M | $-45M | $-77M | $-108M | $67M | $-345M | $-180M | |
| Interest Expense | · | · | $15M | $15M | $15M | · | · | · | · | · | $24M | $20M | |
| Interest Income | $8M | $13M | $6M | $3M | $112.0K | $167.0K | $997.0K | $501.0K | $293.0K | $85.0K | $18.0K | $9.0K | |
| Other Non-op | $-1M | $32.0K | $122.0K | $-102.0K | $-239.0K | $23.0K | $-926.0K | $-437.0K | $13.0K | $-597.0K | $1M | $2M | |
| Pretax Income | $1M | $31M | $-10M | $-87M | $-81M | $-57M | $-52M | $-87M | $-117M | $126M | $-368M | $-198M | |
| Income Tax | $-4M | $3M | $2M | $0 | $0 | $-218.0K | $0 | $240.0K | $51.0K | $0 | $0 | $0 | |
| Net Income | $6M | $28M | $-12M | $-87M | $-81M | $-57M | $-52M | $-87M | $-117M | $126M | $-368M | $-198M | |
| EPS (Basic) | $0.02 | $0.10 | $-0.04 | $-0.34 | $-0.32 | $-0.26 | · | $-0.60 | $-1.13 | $1.37 | $-4.54 | $-2.57 | |
| EPS (Diluted) | $0.02 | $0.10 | $-0.04 | $-0.34 | $-0.32 | $-0.26 | · | $-0.60 | $-1.13 | $1.36 | $-4.54 | $-2.57 | |
| Shares (Basic) | 305,639,000 | 274,415,000 | 267,014,000 | 257,092,000 | 249,244,000 | 222,585,000 | · | 144,136,000 | 104,245,000 | 92,053,000 | 81,233,000 | 77,045,000 | |
| Shares (Diluted) | 314,112,000 | 283,844,000 | 267,014,000 | 257,092,000 | 249,244,000 | 222,585,000 | · | 144,136,000 | 104,245,000 | 92,085,000 | 81,233,000 | 77,045,000 | |
| EBITDA | $39M | $73M | $9M | $-64M | $-47M | $-48M | $-45M | $-77M | $-106M | · | $-334M | $-170M |
बैलेंस शीट
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $75M | $46M | $238M | $70M | $124M | $67M | $30M | $71M | $44M | $23M | $59M | $121M | |
| Short-term Investments | $96M | $151M | $57M | $101M | $80M | $0 | $20M | · | · | · | · | · | |
| Receivables | $38M | $12M | $15M | $17M | $5M | $4M | $4M | $4M | $3M | $302.0K | $23.0K | $50M | |
| Inventory | $35M | $28M | $29M | $22M | $7M | $5M | $4M | $4M | $3M | $2M | · | $10M | |
| Prepaid Expense | $47M | $31M | $35M | $25M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $20M | |
| Current Assets | $292M | $268M | $373M | $235M | $219M | $79M | $61M | $82M | $57M | $77M | $77M | $201M | |
| PP&E (Net) | $82M | $85M | $84M | $45M | $37M | $26M | $27M | $26M | $27M | $29M | $49M | $192M | |
| PP&E (Gross) | $196M | $192M | $186M | $144M | $134M | $123M | $122M | $126M | $128M | $129M | $168M | $310M | |
| Accum. Depreciation | $114M | $107M | $102M | $99M | $98M | $97M | $95M | $100M | $101M | $100M | $120M | $118M | |
| Goodwill | $68M | $2M | $2M | $2M | · | · | · | · | · | · | · | · | |
| Intangibles | $5M | $5M | $1M | $1M | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $20M | $27M | $7M | $10M | $8M | $3M | $6M | $249.0K | $437.0K | $648.0K | $1M | $848.0K | |
| Total Assets | $792M | $394M | $475M | $295M | $321M | $109M | $94M | $108M | $85M | $107M | $126M | $394M | |
| Accounts Payable | $9M | $7M | $10M | $11M | $7M | $6M | $5M | $5M | $7M | $3M | $16M | $7M | |
| Accrued Liabilities | $65M | $40M | $42M | $36M | $27M | $20M | $16M | $15M | $12M | $8M | $8M | $26M | |
| Short-term Debt | · | · | · | · | · | · | $5M | · | · | · | · | · | |
| Current Liabilities | $171M | $82M | $104M | $67M | $48M | $74M | $66M | $75M | $88M | $92M | $268M | $403M | |
| Capital Leases | $11M | $12M | $4M | $5M | $1M | $1M | $3M | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | $5M | · | · | · | · | · | $15M | $12M | |
| Total Liabilities | $843M | $473M | $721M | $546M | $531M | $289M | $284M | $283M | $299M | $291M | $477M | $468M | |
| Long-term Debt | $355M | $36M | $269M | $273M | $281M | $122M | $119M | $102M | $157M | · | · | · | |
| Total Debt | · | · | · | · | · | · | $5M | · | · | · | · | · | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $957.0K | $4M | $4M | |
| Retained Earnings | $-3.20B | $-3.20B | $-3.23B | $-3.22B | $-3.13B | $-3.05B | $-2.99B | $-2.94B | $-2.85B | $-2.74B | $-2.86B | $-2.49B | |
| AOCI | $115.0K | $1M | · | · | · | · | $-19.0K | $-19.0K | $-18.0K | $-24.0K | $-20.0K | $-14.0K | |
| Stockholders' Equity | $-51M | $-79M | $-246M | $-251M | $-209M | $-180M | $-191M | $-175M | $-215M | $-184M | $-350M | $-74M | |
| Liabilities + Equity | $792M | $394M | $475M | $295M | $321M | $109M | $94M | $108M | $85M | $107M | $126M | $394M | |
| Shares Outstanding | 307,832,587 | 302,959,782 | 270,034,495 | 263,793,305 | 251,477,562 | 242,117,089 | 211,787,573 | 187,029,967 | 119,053,414 | 95,680,831 | 85,734,188 | 406,059,089 |
नकदी प्रवाह
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $12M | $7M | $5M | $3M | $2M | $2M | $972.0K | $3M | $2M | $2M | $11M | $10M | |
| Stock-based Comp | $24M | $21M | $18M | $13M | $12M | $7M | $6M | $7M | $5M | $5M | $9M | $49M | |
| Deferred Tax | $-19M | $4M | $7M | $-10M | $-20M | $-5M | $-5M | $-11M | $-260M | $48M | $-80M | $-66M | |
| Amort. of Intangibles | $4M | · | · | · | · | · | · | · | · | · | · | · | |
| Restructuring | · | · | · | · | · | · | · | · | · | $2M | $6M | $2M | |
| Other Non-cash | · | · | · | · | · | · | · | · | $306M | · | $291M | $144M | |
| Operating Cash Flow | $18M | $43M | $34M | $-81M | $-62M | $-28M | $-88M | $-38M | $-65M | $-78M | $-57M | $4M | |
| CapEx | $5M | $10M | $42M | $8M | $11M | $801.0K | $3M | $354.0K | · | $1M | $10M | $24M | |
| Investing Cash Flow | $-305M | $-97M | $-2M | $5M | $-152M | $15M | $-23M | $-234.0K | $17M | $-1M | · | · | |
| Debt Issued | · | · | · | · | · | $5M | · | · | · | · | · | $20M | |
| Net Debt Issued | · | · | · | · | · | $5M | · | · | · | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | · | $564.0K | $893.0K | $28M | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | $564.0K | · | $28M | · | |
| Financing Cash Flow | $315M | $-137M | $137M | $21M | $270M | $50M | $70M | $61M | $74M | $43M | · | · | |
| Net Change in Cash | $29M | $-191M | $169M | $-54M | $57M | $37M | $-41M | $23M | $25M | $-36M | $-62M | $50M | |
| Taxes Paid | $2M | $4M | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $14M | $33M | $-8M | $-88M | $-73M | $-29M | $-91M | $-38M | · | · | $-68M | $-20M | |
| Levered FCF | · | · | $-26M | $-98M | · | · | · | · | · | · | $-92M | · |
लाभप्रदता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 11.1% | 25.4% | 4.4% | -64.3% | -62.3% | -73.6% | -70.8% | -274.9% | -921.1% | · | · | · | |
| Net Margin | 1.7% | 9.7% | -6.0% | -87.6% | -107.3% | -87.9% | -82.3% | -312.2% | -999.0% | · | · | · | |
| Pretax Margin | 0.40% | 10.7% | -5.2% | -87.6% | -107.3% | -88.2% | -82.3% | -311.3% | -998.6% | · | · | · | |
| EBITDA Margin | 11.1% | 25.4% | 4.4% | -64.3% | -62.3% | -73.6% | -70.8% | -274.9% | -905.8% | · | · | · | |
| ROA | 0.99% | 6.3% | -3.1% | -28.4% | -37.7% | -56.6% | -51.5% | -90.5% | -122.4% | · | -141.5% | -60.8% | |
| ROE | -11.1% | -19.1% | 4.8% | 35.8% | 41.1% | 31.2% | 27.7% | 45.7% | 58.9% | · | 173.8% | 379.7% | |
| ROIC | -316.9% | -83.2% | -4.1% | 25.6% | 22.5% | 26.5% | 24.0% | 43.9% | 50.4% | · | 98.4% | · |
तरलता और शोधन क्षमता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 3.3 | 3.6 | 3.5 | 4.5 | 1.1 | 0.9 | 1.1 | 0.7 | · | 0.3 | 0.5 | |
| Quick Ratio | 1.2 | 2.6 | 3.0 | 2.8 | 4.3 | 1.0 | 0.8 | 1.0 | 0.5 | · | 0.2 | 0.4 | |
| Debt / Equity | · | · | · | · | · | · | -0.0 | · | · | · | · | · | |
| Interest Coverage | · | · | 0.6 | -6.7 | · | · | · | · | · | · | -14.3 | -8.8 |
दक्षता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.7 | 0.5 | 0.3 | 0.4 | 0.6 | 0.6 | 0.3 | 0.1 | · | 0.0 | · | |
| Inventory Turnover | 0.8 | 0.6 | 0.8 | 1.1 | 2.8 | 3.3 | 5.2 | 6.2 | 6.9 | · | · | · | |
| Receivables Turnover | 13.9 | 21.4 | 12.6 | 9.3 | 16.4 | 16.9 | 16.7 | 8.2 | 7.6 | · | 0.0 | · |
प्रति शेयर
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.17 | $-0.26 | $-0.91 | $-0.95 | $-0.83 | $-0.75 | $-0.90 | $-0.94 | $-1.80 | · | $-0.82 | $-0.18 | |
| Revenue / Share | $1.11 | $1.01 | $0.75 | $0.39 | · | · | · | $0.19 | $0.11 | · | · | · | |
| Cash Flow / Share | $0.06 | $0.15 | $0.13 | $-0.31 | · | · | · | $-0.26 | $-0.62 | · | · | · | |
| Cash / Share | $0.24 | $0.15 | $0.88 | $0.26 | $0.49 | $0.28 | $0.14 | $0.38 | $0.37 | · | $0.14 | $0.30 | |
| EPS (TTM) | $0.02 | $0.10 | $-0.04 | $-0.34 | $-0.32 | $-0.26 | $-0.63 | $-0.60 | $-1.13 | $1.36 | $-4.54 | $-2.57 |
विकास दरें
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 22.2% | 43.5% | 99.4% | 32.2% | 15.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 51.8% | 55.8% | 45.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 39.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -80.0% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -78.8% | · | · | · | · | · | · | · | · | · | · | · |
मूल्यांकन (TTM)
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $349M | $286M | $199M | $100M | $75M | $65M | $63M | $28M | $12M | $175M | $0 | $0 | |
| Net Income TTM | $6M | $28M | $-12M | $-87M | $-81M | $-57M | $-52M | $-87M | $-117M | $126M | $-368M | $-198M | |
| Market Cap | $1.75B | $1.95B | $983M | $1.39B | $1.10B | $758M | $273M | $198M | $276M | · | $3.11B | $10.60B | |
| Enterprise Value | · | · | · | · | · | · | $228M | · | · | · | · | · | |
| P/E | 283.5 | 64.3 | -91.0 | -15.5 | -13.7 | -12.0 | -2.0 | -1.8 | -2.1 | 2.4 | -1.6 | -10.2 | |
| P/S | 5.0 | 6.8 | 4.9 | 13.9 | 14.6 | 11.6 | 4.3 | 7.1 | 23.5 | · | · | · | |
| P/B | -34.2 | -24.7 | -4.0 | -5.5 | -5.2 | -4.2 | -1.4 | -1.1 | -1.3 | · | -8.9 | -143.7 | |
| P / Cash Flow | 95.6 | 45.8 | 28.8 | -17.2 | -17.8 | -26.9 | -3.1 | -5.3 | -4.3 | · | -54.3 | 2593.8 | |
| P / FCF | 127.5 | 59.4 | -117.8 | -15.7 | -15.0 | -26.2 | -3.0 | -5.2 | · | · | -46.0 | -529.6 | |
| EV / EBITDA | · | · | · | · | · | · | -5.1 | · | · | · | · | · | |
| EV / FCF | · | · | · | · | · | · | -2.5 | · | · | · | · | · | |
| EV / Revenue | · | · | · | · | · | · | 3.6 | · | · | · | · | · | |
| Earnings Yield | 0.35% | 1.6% | -1.1% | -6.5% | -7.3% | -8.3% | -48.8% | -56.6% | -48.7% | 42.5% | -62.6% | -9.8% |
आय विवरण
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $109M | $90M | $112M | $82M | $77M | $78M | $77M | $70M | $72M | $66M | $58M | $51M | $49M | $41M | $36M | $33M | |
| Cost of Revenue | $14M | $8M | $14M | $4M | $5M | $4M | $5M | $3M | $6M | $4M | $6M | $4M | $5M | $6M | $4M | $5M | |
| SG&A Expense | $58M | $54M | $58M | $29M | $32M | $25M | $24M | $24M | $24M | $22M | $61M | $11M | $12M | $11M | $64M | $9M | |
| Operating Expenses | $30M | $92M | $-103M | $63M | $21M | $56M | $-86M | $57M | $56M | $50M | $18M | $14M | $14M | $16M | $16M | $17M | |
| Operating Income | $-350.0K | $-2M | $-8M | $19M | $5M | $22M | $26M | $13M | $17M | $17M | $8M | $5M | $2M | $-6M | $-13M | $-10M | |
| Interest Expense | · | · | · | · | · | · | · | · | $6M | $3M | · | $3M | $7M | $3M | · | $3M | |
| Interest Income | $1M | $1M | $2M | $3M | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $957.0K | $663.0K | |
| Other Non-op | $-5M | $-3M | $23M | $-11M | $-4M | $-9M | $24M | $110.0K | $-18M | $-6M | $-164.0K | $318.0K | $-143.0K | $111.0K | $105.0K | $-207.0K | |
| Pretax Income | $-19M | $-16M | $-21M | $8M | $940.0K | $14M | $8M | $13M | $-2M | $11M | $3M | $2M | $-5M | $-10M | $-18M | $-14M | |
| Income Tax | $-106.0K | $253.0K | $-5M | $-204.0K | $272.0K | $459.0K | $1M | $1M | $323.0K | $264.0K | $2M | $0 | $0 | $0 | · | $0 | |
| Net Income | $-19M | $-17M | $-16M | $8M | $668.0K | $13M | $7M | $12M | $-2M | $11M | $1M | $2M | $-5M | $-10M | $-18M | $-14M | |
| EPS (Basic) | $-0.06 | $-0.05 | $-0.05 | $0.03 | $0.00 | $0.04 | $0.03 | $0.04 | $-0.01 | $0.04 | $0.01 | $0.01 | $-0.02 | $-0.04 | $-0.07 | $-0.06 | |
| EPS (Diluted) | $-0.06 | $-0.05 | $-0.05 | $0.03 | $0.00 | $0.04 | $0.03 | $0.04 | $-0.01 | $0.04 | $0.01 | $0.01 | $-0.02 | $-0.04 | $-0.07 | $-0.06 | |
| Shares (Basic) | 309,191,000 | 308,267,000 | · | 306,806,000 | 304,954,000 | 303,481,000 | · | 274,998,000 | 273,056,000 | 270,356,000 | · | 268,732,000 | 265,626,000 | 263,969,000 | · | 259,300,000 | |
| Shares (Diluted) | 309,191,000 | 308,267,000 | · | 311,638,000 | 311,484,000 | 320,897,000 | · | 284,693,000 | 273,056,000 | 324,733,000 | · | 323,770,000 | 265,626,000 | 263,969,000 | · | 259,300,000 | |
| EBITDA | · | $-2M | · | $19M | $5M | $22M | · | $13M | $17M | $17M | · | $5M | $2M | $-6M | · | $-10M |
बैलेंस शीट
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $53M | $53M | $75M | $127M | $57M | $47M | $46M | $62M | $97M | $193M | · | $83M | $86M | $86M | · | $54M | |
| Short-term Investments | $58M | $81M | $96M | $133M | $122M | $134M | $151M | $189M | $151M | $107M | · | $58M | $58M | $80M | · | $111M | |
| Receivables | $43M | $28M | $38M | $17M | $27M | $29M | $12M | $18M | $23M | $20M | · | $22M | $28M | $20M | · | $23M | |
| Inventory | $44M | $49M | $35M | $27M | $28M | $29M | $28M | $27M | $25M | $26M | · | $27M | $25M | $22M | · | $18M | |
| Prepaid Expense | $47M | $40M | $47M | $54M | $44M | $34M | $31M | $31M | $30M | $36M | · | $36M | $33M | $15M | · | $12M | |
| Current Assets | $246M | $251M | $292M | $359M | $279M | $274M | $268M | $328M | $326M | $383M | · | $226M | $230M | $223M | · | $218M | |
| PP&E (Net) | $85M | $83M | $82M | $83M | $83M | $84M | $85M | $85M | $85M | $84M | · | $80M | $70M | $55M | · | $41M | |
| PP&E (Gross) | $203M | $198M | $196M | $195M | $194M | $192M | $192M | $192M | $190M | $186M | · | $182M | $170M | $154M | · | $140M | |
| Accum. Depreciation | $118M | $116M | $114M | $113M | $111M | $109M | $107M | $107M | $105M | $103M | · | $101M | $100M | $100M | · | $99M | |
| Goodwill | $68M | $68M | $68M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $3M | |
| Intangibles | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $1M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Other Non-current Assets | $17M | $22M | $20M | $19M | $20M | $28M | $27M | $26M | $16M | $7M | · | $8M | $8M | $16M | · | $17M | |
| Total Assets | $732M | $744M | $792M | $495M | $412M | $410M | $394M | $464M | $444M | $481M | · | $320M | $313M | $298M | · | $294M | |
| Accounts Payable | $11M | $16M | $9M | $7M | $10M | $5M | $7M | $6M | $10M | $7M | · | $17M | $17M | $14M | · | $10M | |
| Accrued Liabilities | $61M | $59M | $65M | $31M | $31M | $40M | $40M | $37M | $41M | $42M | · | $32M | $37M | $33M | · | $30M | |
| Current Liabilities | $143M | $135M | $171M | $109M | $112M | $116M | $82M | $72M | $80M | $100M | · | $96M | $97M | $82M | · | $60M | |
| Capital Leases | $10M | $10M | $11M | $10M | $11M | $11M | $12M | $12M | $3M | $4M | · | $4M | $5M | $5M | · | $6M | |
| Total Liabilities | $800M | $804M | $843M | $539M | $467M | $469M | $473M | $674M | $670M | $711M | · | $572M | $574M | $554M | · | $532M | |
| Long-term Debt | $319M | $319M | $355M | $110M | $36M | $36M | $36M | $228M | $228M | $264M | · | $273M | $274M | $274M | · | $273M | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M | |
| Retained Earnings | $-3.23B | $-3.21B | $-3.20B | $-3.18B | $-3.19B | $-3.19B | $-3.20B | $-3.21B | $-3.22B | $-3.22B | · | $-3.23B | $-3.23B | $-3.23B | · | $-3.20B | |
| AOCI | $-19.0K | $-4.0K | $115.0K | $137.0K | $1M | $1M | $1M | $588.0K | · | · | · | $443.0K | $443.0K | · | · | $-1M | |
| Stockholders' Equity | $-67M | $-59M | $-51M | $-45M | $-55M | $-59M | $-79M | $-210M | $-226M | $-230M | $-246M | $-252M | $-260M | $-255M | $-251M | $-238M | |
| Liabilities + Equity | $732M | $744M | $792M | $495M | $412M | $410M | $394M | $464M | $444M | $481M | · | $320M | $313M | $298M | · | $294M | |
| Shares Outstanding | 309,911,682 | 308,907,331 | 307,832,587 | 307,027,189 | 306,332,133 | 303,918,969 | 302,959,782 | 275,775,038 | 274,467,247 | 270,801,781 | · | 269,543,539 | 268,235,145 | 264,278,760 | · | 263,156,165 |
नकदी प्रवाह
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $6M | $6M | $6M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $-427.0K | |
| Stock-based Comp | $10M | $6M | $7M | $4M | $8M | $5M | $6M | $5M | $6M | $4M | $4M | $5M | $6M | $4M | $3M | $4M | |
| Amort. of Intangibles | $4M | $4M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-18M | $-5M | $-8M | $24M | $9M | $-6M | $23M | $9M | $4M | $7M | $22M | $9M | $3M | $1M | $-2M | $-28M | |
| CapEx | $5M | $2M | $2M | $1M | $1M | $330.0K | $3M | $1M | $3M | $2M | $6M | $11M | $17M | $8M | $5M | $271.0K | |
| Investing Cash Flow | $18M | $19M | $-292M | $-25M | $6M | $6M | $48M | $-41M | $-55M | $-48M | $-8M | $-12M | $4M | $14M | $15M | $27M | |
| Financing Cash Flow | $559.0K | $-35M | $247M | $72M | $-6M | $1M | $-87M | $-2M | $-45M | $-3M | $142M | $-283.0K | $-6M | $1M | $3M | $20M | |
| Net Change in Cash | $97.0K | $-22M | $-53M | $70M | $10M | $975.0K | $-16M | $-34M | $-96M | $-45M | $155M | $-3M | $315.0K | $16M | $15M | $19M | |
| Taxes Paid | $753.0K | $63.0K | $549.0K | $80.0K | $869.0K | $207.0K | $2M | $236.0K | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $-7M | · | · | · | $-7M | · | · | · | $4M | · | · | · | $-7M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $2M | · | · | · | $-10M | · | · |
लाभप्रदता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -1.8% | · | 23.0% | 6.9% | 28.4% | · | 18.2% | 22.9% | 25.2% | · | 9.9% | 3.5% | -14.8% | · | -29.3% | |
| Net Margin | · | -18.4% | · | 9.7% | 0.87% | 16.8% | · | 16.5% | -2.8% | 16.0% | · | 3.4% | -10.8% | -24.1% | · | -44.0% | |
| Pretax Margin | · | -18.1% | · | 9.5% | 1.2% | 17.4% | · | 18.4% | -2.3% | 16.4% | · | 3.4% | -10.8% | -24.1% | · | -44.0% | |
| EBITDA Margin | · | -1.8% | · | 23.0% | 6.9% | 28.4% | · | 18.2% | 22.9% | 25.2% | · | 9.9% | 3.5% | -14.8% | · | -29.3% | |
| ROA | · | -2.9% | · | 1.7% | 0.16% | 2.9% | · | 2.9% | -0.53% | 2.7% | · | 0.56% | -1.8% | -3.2% | · | -5.4% | |
| ROE | · | 28.2% | · | -6.3% | -0.48% | -9.1% | · | -5.0% | 0.83% | -4.4% | · | -0.70% | 2.1% | 4.0% | · | 6.8% | |
| ROIC | · | 2.9% | · | -43.5% | -6.8% | -36.8% | · | -5.5% | -8.8% | -7.1% | · | -2.0% | -0.66% | 2.4% | · | · |
तरलता और शोधन क्षमता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 1.9 | · | 3.3 | 2.5 | 2.4 | · | 4.5 | 4.1 | 3.8 | · | 2.3 | 2.4 | 2.7 | · | 3.7 | |
| Quick Ratio | · | 1.2 | · | 2.5 | 1.8 | 1.8 | · | 3.7 | 3.4 | 3.2 | · | 1.7 | 1.8 | 2.3 | · | 3.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | 2.7 | 6.5 | · | 1.8 | 0.3 | -2.5 | · | · |
दक्षता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | |
| Inventory Turnover | · | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.4 | · | 0.4 | |
| Receivables Turnover | · | 3.2 | · | 4.6 | 3.0 | 3.2 | · | 3.5 | 2.8 | 3.3 | · | 2.3 | 2.3 | 2.8 | · | 2.0 |
प्रति शेयर
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $-0.19 | · | $-0.15 | $-0.18 | $-0.19 | · | $-0.76 | $-0.82 | $-0.85 | · | $-0.93 | $-0.97 | $-0.97 | · | $-0.90 | |
| Revenue / Share | · | $0.29 | · | $0.26 | $0.25 | $0.24 | · | $0.25 | $0.27 | $0.20 | · | $0.16 | $0.18 | $0.15 | · | $0.13 | |
| Cash Flow / Share | · | $-0.02 | · | · | · | $-0.02 | · | · | · | $0.02 | · | · | · | $0.00 | · | · | |
| Cash / Share | · | $0.17 | · | $0.41 | $0.19 | $0.16 | · | $0.23 | $0.35 | $0.71 | · | $0.31 | $0.32 | $0.32 | · | $0.21 | |
| EPS (TTM) | $-0.08 | $-0.07 | · | $0.10 | $0.11 | $0.10 | · | $0.08 | $0.05 | $0.04 | · | $-0.12 | $-0.19 | $-0.28 | · | $-0.38 |
मूल्यांकन (TTM)
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $358M | $361M | · | $314M | $302M | $298M | · | $267M | $248M | $225M | · | $177M | $158M | $128M | · | $76M | |
| Net Income TTM | $-27M | $-24M | · | $29M | $33M | $30M | · | $22M | $12M | $8M | · | $-31M | $-47M | $-71M | · | $-98M | |
| Market Cap | · | $757M | · | $1.65B | $1.15B | $1.53B | · | $1.73B | $1.43B | $1.23B | · | $1.11B | $1.09B | $1.08B | · | $813M | |
| P/E | -53.2 | -35.0 | · | 53.7 | 34.0 | 50.3 | · | 78.6 | 104.4 | 113.2 | · | -34.4 | -21.4 | -14.6 | · | -8.1 | |
| P/S | · | 2.1 | · | 5.3 | 3.8 | 5.1 | · | 6.5 | 5.8 | 5.5 | · | 6.3 | 6.9 | 8.4 | · | 10.7 | |
| P/B | · | -12.8 | · | -37.0 | -20.8 | -26.1 | · | -8.3 | -6.3 | -5.3 | · | -4.4 | -4.2 | -4.2 | · | -3.4 | |
| P / Cash Flow | · | -141.1 | · | · | · | -239.7 | · | · | · | 183.0 | · | · | · | 937.3 | · | · | |
| Earnings Yield | -1.9% | -2.9% | · | 1.9% | 2.9% | 2.0% | · | 1.3% | 0.96% | 0.88% | · | -2.9% | -4.7% | -6.8% | · | -12.3% |
सबसे हाल की अवधि बाईं ओर · शून्य मान इस प्रकार दिखाए गए हैं ·
वित्तीय विवरण आय विवरण, बैलेंस शीट, नकदी प्रवाह — वार्षिक, पिछले 5 वर्ष
| मेट्रिक | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| राजस्व | $349M | $286M | $199M | $100M | $75M |
| परिचालन मार्जिन % | 11.1% | 25.4% | 4.4% | -64.3% | -62.3% |
| शुद्ध आय | $6M | $28M | $-12M | $-87M | $-81M |
| तनुकरणित EPS | $0.02 | $0.10 | $-0.04 | $-0.34 | $-0.32 |
| मेट्रिक | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| वर्तमान अनुपात | 1.7 | 3.3 | 3.6 | 3.5 | 4.5 |
| त्वरित अनुपात | 1.2 | 2.6 | 3.0 | 2.8 | 4.3 |
| मेट्रिक | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| फ्री कैश फ्लो | $14M | $33M | $-8M | $-88M | $-73M |
संस्थागत मालिक (13F) 271 फाइलर्स · $883.4M कुल · तिथि अनुसार 30 सितमबर 2026
संस्थान जो अपनी तिमाही SEC फॉर्म 13F में इस स्टॉक को होल्ड करने की रिपोर्ट करते हैं। केवल लॉन्ग पोजीशन; एक ही फाइलर अलग-अलग ऑप्शन लेग्स के लिए दो बार दिखाई दे सकता है। बड़े ऑफसेटिंग पुट/कॉल लेग्स आमतौर पर मार्केट-मेकिंग या हेज्ड इन्वेंट्री को दर्शाते हैं, न कि दिशात्मक विश्वास को।
धारक
271
धारित मूल्य
$883.4M
नई स्थितियाँ
51
बाहर निकली पोजीशन
39
संस्थागत गतिविधि — Q2 2026 बनाम पिछली तिमाही
| नई स्थितियाँ | बाहर निकली पोजीशन | बढ़ाया | घटा हुआ | शुद्ध शेयर परिवर्तन |
|---|---|---|---|---|
| 51 (0 पिछली तिमाही की तुलना में) | 39 (-8 पिछली तिमाही की तुलना में) | 98 (+12 पिछली तिमाही की तुलना में) | 63 (-7 पिछली तिमाही की तुलना में) | +1.9M |
Q1 2026 की तुलना में। SEC फॉर्म 13F फाइलिंग तिमाही के अंत के 45 दिनों के भीतर देय होती है, साथ ही देर से फाइल करने वालों के लिए एक छोटा बफर भी होता है — उस विंडो के भीतर आने वाली तिमाहियों को सबसे हालिया पूरी तरह से रिपोर्ट की गई जोड़ी के पक्ष में छोड़ दिया जाता है।
| संस्था | मूल्य | शेयर | % ट्रैक किए गए 13F का | प्रकार |
|---|---|---|---|---|
| BlackRock, Inc. | $136887530 | 32133223 | 15.50% | शेयर |
| VANGUARD GROUP INC | $101384549 | 17880873 | 11.48% | शेयर |
| Rubric Capital Management LP | $76680000 | 18000000 | 8.68% | शेयर |
| STATE STREET CORP | $68901423 | 16174043 | 7.80% | शेयर |
| VANGUARD CAPITAL MANAGEMENT LLC | $56101610 | 13169392 | 6.35% | शेयर |
| GEODE CAPITAL MANAGEMENT, LLC | $33861886 | 7947203 | 3.83% | शेयर |
| WELLINGTON MANAGEMENT GROUP LLP | $33418878 | 7844807 | 3.78% | शेयर |
| Frazier Life Sciences Management, L.P. | $28116000 | 6600000 | 3.18% | शेयर |
| Deep Track Capital, LP | $25560000 | 6000000 | 2.89% | शेयर |
| 180 WEALTH ADVISORS, LLC | $21126835 | 4959351 | 2.39% | शेयर |
| FMR LLC | $17470455 | 4101046 | 1.98% | शेयर |
| TSP Capital Management Group, LLC | $16923596 | 3972675 | 1.92% | शेयर |
| AQR CAPITAL MANAGEMENT LLC | $16225589 | 3808824 | 1.84% | शेयर |
| MORGAN STANLEY | $14802946 | 3474870 | 1.68% | शेयर |
| BRAIDWELL LP | $14732908 | 3458429 | 1.67% | शेयर |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $12789240 | 3002169 | 1.45% | शेयर |
| NORTHERN TRUST CORP | $12299856 | 2887290 | 1.39% | शेयर |
| UBS Group AG | $12295344 | 2886231 | 1.39% | शेयर |
| TWO SIGMA INVESTMENTS, LP | $11475213 | 2693712 | 1.30% | शेयर |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $11070577 | 2598727 | 1.25% | शेयर |
| BANK OF AMERICA CORP /DE/ | $10074356 | 2364872 | 1.14% | शेयर |
| VANGUARD FIDUCIARY TRUST CO | $9358279 | 2196779 | 1.06% | शेयर |
| GOLDMAN SACHS GROUP INC | $9178165 | 2154499 | 1.04% | शेयर |
| WELLS FARGO & COMPANY/MN | $6289519 | 1476413 | 0.71% | शेयर |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5030221 | 1180803 | 0.57% | शेयर |
| DIMENSIONAL FUND ADVISORS LP | $4661185 | 1094192 | 0.53% | शेयर |
| Caption Management, LLC | $4260000 | 1000000 | 0.48% | पुट ऑप्शन |
| Bank of New York Mellon Corp | $3827454 | 898463 | 0.43% | शेयर |
| CITADEL ADVISORS LLC | $3818068 | 896260 | 0.43% | शेयर |
| J. Goldman & Co LP | $3478669 | 816589 | 0.39% | शेयर |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $3019973 | 1232642 | 0.34% | शेयर |
| SCOPIA CAPITAL MANAGEMENT LP | $2960534 | 694961 | 0.34% | शेयर |
| Balyasny Asset Management L.P. | $2914296 | 684107 | 0.33% | शेयर |
| TWO SIGMA ADVISERS, LP | $2897166 | 510964 | 0.33% | शेयर |
| VICTORY CAPITAL MANAGEMENT INC | $2771407 | 650565 | 0.31% | शेयर |
| Nuveen, LLC | $2708218 | 635732 | 0.31% | शेयर |
| Swiss National Bank | $2502324 | 587400 | 0.28% | शेयर |
| STATE OF WISCONSIN INVESTMENT BOARD | $2177052 | 511045 | 0.25% | शेयर |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $2106540 | 494493 | 0.24% | शेयर |
| 1492 Capital Management LLC | $2052136 | 481722 | 0.23% | शेयर |
| Mariner, LLC | $2020189 | 474236 | 0.23% | शेयर |
| MILLENNIUM MANAGEMENT LLC | $1836597 | 431126 | 0.21% | शेयर |
| Schonfeld Strategic Advisors LLC | $1774216 | 416483 | 0.20% | शेयर |
| Squarepoint Ops LLC | $1759644 | 413062 | 0.20% | शेयर |
| Jefferies Financial Group Inc. | $1694202 | 397700 | 0.19% | शेयर |
| ExodusPoint Capital Management, LP | $1666261 | 391141 | 0.19% | शेयर |
| JANE STREET GROUP, LLC | $1658418 | 389300 | 0.19% | कॉल ऑप्शन |
| PRINCIPAL FINANCIAL GROUP INC | $1629561 | 382526 | 0.18% | शेयर |
| Man Group plc | $1624023 | 381226 | 0.18% | शेयर |
| RHUMBLINE ADVISERS | $1604647 | 376681 | 0.18% | शेयर |
कार्यकर्ता और 5%+ मालिक 2 होल्डिंग्स
जिन निवेशकों ने SEC शेड्यूल 13D दाखिल किया है — जारीकर्ता को प्रभावित करने के इरादे से 5% से अधिक लाभकारी स्वामित्व (कार्यकर्ता दांव, बोर्ड अभियान, M&A)। प्रत्येक पंक्ति उस फाइलर की स्थिति की सबसे हालिया ज्ञात स्थिति दिखाती है।
| फाइलर | दाखिल किया | दांव | स्थिति | उद्देश्य | फाइलिंग |
|---|---|---|---|---|---|
| Alfred E. Mann, Alfred E. Mann Living Trust, Biomed Partners, LLC, Minimed Infusion, Inc., The Mann Group LLC ×2 फाइलिंग | 10 जुलाई 2012 | · | प्रारंभिक फाइलिंग | निष्क्रिय निवेश | SEC |
| अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति | 31 जनवरी 2006 | · | प्रारंभिक फाइलिंग | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
कंपनी के अंदरूनी सूत्र 43 इनसाइडर्स · 27 अधिकारी · 19 निदेशक
| अंदरूनी | भूमिका | अंतिम गतिविधि | शेयरों का स्वामित्व | खरीद 12m | बिक्री 12m | नेट 12m |
|---|---|---|---|---|---|---|
| Michael Castagna | Chief Executive Officer | 15 जुलाई 2026 M | 2433779 | 1 | 4 | $-990292 |
| Hakan Edstrom | President & CEO | 27 अगस्त 2015 A | 1114340 | 0 | 0 | $0 |
| Christopher B Prentiss | Chief Financial Officer | 15 जुलाई 2026 F | 318668 | 0 | 0 | $0 |
| Juergen Martens | Corporate VP and COO | 27 अगस्त 2015 A | 106539 | 0 | 0 | $0 |
| Dominic Marasco | Pres, Endocrine Business Unit | 15 जुलाई 2026 F | 343398 | 0 | 0 | $0 |
| Sanjay R Singh | EVP Technical Operations | 15 जुलाई 2026 M | 478966 | 0 | 1 | $-94448 |
| Stuart A Tross | Chief People & Workpl Officer | 15 जुलाई 2026 M | 1058142 | 0 | 1 | $-297548 |
| David Thomson | EVP Genl Counsel & Secretary | 15 जुलाई 2026 M | 797554 | 0 | 3 | $-930755 |
| Ajay Ahuja | Chief Medical Officer | 23 मार्च 2026 A | 318200 | 0 | 0 | $0 |
| Lauren M Sabella | EVP Operations | 15 जुलाई 2025 F | 349841 | 0 | 0 | $0 |
| Burkhard Blank | EVP Chief Medical Officer | 15 जुलाई 2025 F | 460791 | 0 | 0 | $0 |
| Joseph Kocinsky | Chief Technology Officer | 27 अगस्त 2022 F | 745233 | 0 | 0 | $0 |
| Alejandro Galindo | EVP Endocrine Business Unit | 28 फ़रवरी 2022 A | 576690 | 0 | 0 | $0 |
| Rosabel Realica Alinaya | VP, IR & Treasury | 27 अगस्त 2020 A | 167119 | 0 | 0 | $0 |
| David M Kendall | Chief Medical Officer | 31 जुलाई 2020 P | 41059 | 0 | 0 | $0 |
| Patrick Mccauley | Chief Commercial Officer | 25 फ़रवरी 2020 A | 83972 | 0 | 0 | $0 |
| Courtney Barton | Chief Compl & Privacy Officer | 31 जुलाई 2019 P | 29584 | 0 | 0 | $0 |
| Elizabeth Garrett Ingram | Chief Marketing Officer | 14 मई 2019 A | 43012 | 0 | 0 | $0 |
| Raymond W. Urbanski | Corp VP, CMO | 10 अगस्त 2017 S | 2924 | 0 | 0 | $0 |
| Linda A Adreveno | Sr. VP, HR | 18 फ़रवरी 2016 A | 92200 | 0 | 0 | $0 |
| Alfred E Mann | Executive Chairman | 22 अगस्त 2015 F | 1005990 | 0 | 0 | $0 |
| Diane Palumbo | Vice President, Human Resource | 23 फ़रवरी 2015 F | 50624 | 0 | 0 | $0 |
| Peter C Richardson | Chief Scientific Officer | 3 मार्च 2012 F | 133611 | 0 | 0 | $0 |
| Richard L Anderson | Corporate VP | 16 नवमबर 2008 F | 204401 | 0 | 0 | $0 |
| John R. Riesenberger | VP & Chief Commercial Officer | 13 अगस्त 2008 A | 14650 | 0 | 0 | $0 |
| Dan Burns | VP & President, MKBP | 8 दिसमबर 2006 A | 14800 | 0 | 0 | $0 |
| Wendell W Cheatham | VP, Medical & Reg Affairs | 19 अगस्त 2004 A | 300 | 0 | 0 | $0 |
| Steven B. Binder | निदेशक | 25 सितमबर 2026 S | 713258 | 0 | 5 | $-683703 |
| Sabrina Kay | निदेशक | 20 मई 2026 A | 265600 | 0 | 0 | $0 |
| Jennifer Grancio | निदेशक | 20 मई 2026 A | 244815 | 0 | 0 | $0 |
| James Samuel Shannon | निदेशक | 20 मई 2026 A | 64635 | 0 | 0 | $0 |
| Michael A Friedman | निदेशक | 20 मई 2026 A | 47500 | 0 | 0 | $0 |
| Anthony C Hooper | निदेशक | 20 मई 2026 A | 236153 | 0 | 0 | $0 |
| Christine Mundkur | निदेशक | 20 मई 2026 A | 254493 | 0 | 0 | $0 |
| Ronald J Consiglio | निदेशक | 20 मई 2026 A | 132342 | 0 | 0 | $0 |
| Kent Kresa | निदेशक | 15 मई 2024 A | 274541 | 0 | 0 | $0 |
| Henry L Nordhoff | निदेशक | 14 मई 2019 A | 103426 | 0 | 0 | $0 |
| David Maccallum | निदेशक | 16 मई 2018 A | 114790 | 0 | 0 | $0 |
| Matthew J Pfeffer | निदेशक | 28 अगस्त 2017 F | 81961 | 0 | 0 | $0 |
| Abraham E Cohen | निदेशक | 17 अगस्त 2012 S | 56424 | 0 | 0 | $0 |
| Heather Hay Murren | निदेशक | 13 अगस्त 2008 A | 10100 | 0 | 0 | $0 |
| Kathleen Connell | निदेशक | 25 मई 2006 A | · | 0 | 0 | $0 |
| Llew Keltner | निदेशक | 25 मई 2006 A | · | 0 | 0 | $0 |
SEC फॉर्म 3/4/5 फाइलिंग से अंदरूनी सूत्र; नेट = केवल ओपन-मार्केट P/S
ईटीएफ स्वामित्व 29 ETFs द्वारा धारित
वजन केवल प्रत्यक्ष इक्विटी होल्डिंग्स (N-PORT) को दर्शाता है; लीवरेज्ड या डेरिवेटिव-आधारित फंड में अतिरिक्त स्वैप एक्सपोजर हो सकता है जो नहीं दिखाया गया है।
| फंड | भार | इकाइयाँ | तिथि अनुसार | स्रोत |
|---|---|---|---|---|
| JSMD · Janus Detroit Street Trust | 0.62% | 1678187 NS | 31 जुलाई 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0.52% | 29891 SH | 2 अक्टूबर 2026 | दैनिक |
| JSML · Janus Detroit Street Trust | 0.49% | 450643 NS | 31 जुलाई 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0.37% | 1212660 NS | 31 जुलाई 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.23% | 289432 NS | 31 जुलाई 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0.12% | 409547 NS | 31 जुलाई 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.09% | 22737 SH | 2 अक्टूबर 2026 | दैनिक |
| IBB · iShares Trust | 0.08% | 2264902 SH | 11 सितमबर 2026 | दैनिक |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.08% | 330117 SH | 19 अगस्त 2026 | दैनिक |
| IWO · iShares Trust | 0.08% | 2877921 SH | 11 सितमबर 2026 | दैनिक |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.07% | 109855 NS | 31 जुलाई 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0.06% | 3954 NS | 31 जुलाई 2026 | N-PORT |
| ESML · iShares Trust | 0.05% | 333357 SH | 11 सितमबर 2026 | दैनिक |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.04% | 1771496 SH | 19 अगस्त 2026 | दैनिक |
| RSSL · Global X Funds | 0.04% | 147059 NS | 31 जुलाई 2026 | N-PORT |
| ISCG · iShares Trust | 0.04% | 96772 SH | 11 सितमबर 2026 | दैनिक |
| IWM · iShares Trust | 0.04% | 7845946 SH | 11 सितमबर 2026 | दैनिक |
| VHT · VANGUARD WORLD FUND | 0.02% | 874372 SH | 19 अगस्त 2026 | दैनिक |
| FHLC · FIDELITY COVINGTON TRUST | 0.02% | 139696 NS | 31 जुलाई 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.01% | 3543398 SH | 19 अगस्त 2026 | दैनिक |
| WSML · iShares Trust | 0.01% | 16637 SH | 11 सितमबर 2026 | दैनिक |
| TILT · FlexShares Trust | 0.00% | 23700 NS | 31 जुलाई 2026 | N-PORT |
| ITOT · iShares Trust | 0.00% | 465405 SH | 11 सितमबर 2026 | दैनिक |
| IWV · iShares Trust | 0.00% | 84120 SH | 10 सितमबर 2026 | दैनिक |
| DFAC · Dimensional ETF Trust | 0.00% | 58407 NS | 31 जुलाई 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.00% | 11291 NS | 31 जुलाई 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 9327332 SH | 19 अगस्त 2026 | दैनिक |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 26184 SH | 19 अगस्त 2026 | दैनिक |
| ISCB · iShares Trust | · | 13557 SH | 11 सितमबर 2026 | दैनिक |
MNKD विश्लेषक सर्वसम्मति तेजी और मंदी के विश्लेषक राय, 12-महीने का मूल्य लक्ष्य, अपसाइड
रेटिंग · 14 विश्लेषक
खरीदें
मध्यिका लक्ष्य
$7.50
+97.4%
4 28.6%
मजबूत खरीद
8 57.1%
खरीदें
2 14.3%
होल्ड
0 0.0%
बेचें
0 0.0%
मजबूत बिक्री
12-महीने का मूल्य लक्ष्य
8 विश्लेषक · 2026-09-28माध्य लक्ष्य $7.97 +109.7%
← सभी लक्ष्यों से नीचे
वर्तमान मूल्य $3.80
निम्न$4.75
माध्य$7.97
उच्च$13.00
सहकर्मी तुलना (GICS उप-उद्योग) प्रमुख मेट्रिक्स बनाम सेक्टर के साथी
वित्तीय वर्ष के आधार पर, प्रत्येक कंपनी के पिछले वित्तीय वर्ष के अंत के बंद भाव के अनुसार कीमतें।
| टिकर | मार्केट कैप | P/E | राजस्व YoY | शुद्ध मार्जिन | ROE | सकल मार्जिन |
|---|---|---|---|---|---|---|
| MNKD | $1.75B | 283.5 | 22.2% | 1.7% | -11.1% | · |
| ORIC | $806M | -5.6 | · | · | -36.5% | · |
| DMRA | · | · | 38.3% | -17981.1% | -167.0% | · |
| REPL | $633M | -2.3 | · | · | -146.2% | · |
| TRAX | · | · | · | · | · | · |
| BCAX | $953M | -6.7 | · | · | -33.0% | · |
| VOR | $506M | -0.2 | · | · | 83.4% | · |
| MGTX | $645M | -5.6 | 144.6% | -140.3% | 8062.2% | · |
| JANX | $833M | -7.5 | -5.5% | -1136.2% | -11.7% | · |
ताज़ा समाचार इस कंपनी का उल्लेख करने वाली हालिया सुर्खियां
Wells Fargo Calls MannKind Corporation (MNKD)’s Commercial Potential a “Show-Me Story”
Yahoo Finance · 3 months, 2 weeks पहले
MannKind (MNKD) Advances Clinical Trials for Inhaled IPF Therapy
Yahoo Finance · 3 months, 3 weeks पहले
H.C. Wainwright और वेल्स फ़ार्गो ने MannKind (MNKD) के मूल्य लक्ष्यों को बढ़ाया
Yahoo Finance · 4 months, 2 weeks पहले
क्या MannKind Corporation (MNKD) रॉबिनहुड पर खरीदने के लिए लोकप्रिय पैनी स्टॉक्स में से एक है?
Yahoo Finance · 6 months पहले
ट्रेडिंग सिग्नल प्रवेश मूल्य और जोखिम/इनाम अनुपात के साथ हालिया खरीद/बिक्री संकेत
अभी कोई खुला सिग्नल नहीं — कोई कार्ड भरा नहीं है, और यह ईमानदार है।
मेरे मेट्रिक्स आपकी व्यक्तिगत वॉचलिस्ट — पूर्ण फंडामेंटल से चयनित पंक्तियाँ
उन मेट्रिक्स को चुनें जो आपके लिए मायने रखते हैं — ऊपर फुल फंडामेंटल्स में किसी भी पंक्ति के बगल में + पर क्लिक करें।
आपका चयन सहेजा गया है और यह सभी टिकर में आपके साथ रहता है।
स्रोत: SEC 10-Q अग 5, 2026 को फाइल किया गया